Industry’s CER Efforts Should Follow PCORI Methods, Cmte. Member Yancy Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Pharma companies’ comparative effectiveness research should be “in sync” with nationalized approach that the Patient-Centered Outcomes Research Institute will bring, Clyde Yancy, member of the new institute’s Methodology Committee, suggests.